AIA
NVO

Angeles Investment Advisors’s Novo Nordisk NVO Stock Holding History

Angeles Investment Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,186
Closed -$274K – 146
2024
Q4 		$274K Sell
3,186
-624
-16% -$67.5K 0.01% 150
2024
Q3 		$454K Sell
3,810
-29
-0.8% -$3.87K 0.02% 113
2024
Q2 		$548K Buy
3,839
+1,961
+104% +$260K 0.03% 93
2024
Q1 		$241K Buy
+1,878
New +$224K 0.01% 192
2023
Q3 		– Sell
-6,368
Closed -$515K – 206
2023
Q2 		$515K Sell
6,368
-310
-5% -$25.3K 0.04% 63
2023
Q1 		$531K Buy
6,678
+1,490
+29% +$106K 0.04% 55
2022
Q4 		$351K Buy
+5,188
New +$304K 0.03% 66

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Angeles Investment Advisors's NVO Position: Q1 2025 in Review

Angeles Investment Advisors sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 3,186 shares — an estimated $274K sold.

Angeles Investment Advisors first reported a position in NVO in Q4 2022 and held it in 7 quarters. The position peaked at $548K in Q2 2024. 1,528 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • Angeles Investment Advisors reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • Angeles Investment Advisors sold 3,186 Novo Nordisk shares in Q1 2025, an estimated $274K.
  • Angeles Investment Advisors first reported a position in Novo Nordisk in Q4 2022 and held it in 7 quarters.
  • Angeles Investment Advisors's Novo Nordisk position peaked at $548K in Q2 2024.
  • 1,528 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on Angeles Investment Advisors's 13F filing for Q1 2025, filed 15 May 2025.